The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis
- PMID: 27761574
- DOI: 10.1160/TH16-06-0450
The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis
Abstract
Some studies suggest that patients with cirrhosis have an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE). Unfortunately, available data on this association are contrasting. It was the objective of this study to perform a systematic review and meta-analysis of literature to evaluate the risk of venous thromboembolism (VTE) associated with cirrhosis. Studies reporting on VTE risk associated with cirrhosis were systematically searched in the PubMed, Web of Science, Scopus and EMBASE databases. Eleven studies (15 data-sets) showed a significantly increased VTE risk in 695,012 cirrhotic patients as compared with 1,494,660 non-cirrhotic controls (OR: 1.703; 95 %CI: 1.333, 2.175; P<0.0001). These results were confirmed when specifically considering the risk of DVT (7 studies, OR: 2.038; 95 %CI: 1.817, 2.285; P<0.0001) and the risk of PE (5 studies, OR: 1.655; 95 %CI: 1.042, 2.630; p=0.033). The increased VTE risk associated with cirrhosis was consistently confirmed when analysing nine studies reporting adjusted risk estimates (OR: 1.493; 95 %CI: 1.266, 1.762; p<0.0001), and after excluding studies specifically enrolling populations exposed to transient risk factors for VTE (OR: 1.689; 95 %CI: 1.321, 2.160; p<0.0001). Meta-regression models suggested that male gender may significantly impact on the risk of VTE associated with cirrhosis. Results of our meta-analysis suggest that cirrhotic subjects may exhibit an increased risk of VTE. This should be considered to plan specific prevention strategies in this clinical setting.
Keywords: Deep venous thrombosis; cirrhosis; pulmonary embolism; thromboembolism; thrombosis.
Comment in
-
Cirrhosis as a risk factor for venous thrombosis.Thromb Haemost. 2017 Jan 5;117(1):3-5. doi: 10.1160/TH16-10-0782. Epub 2016 Oct 27. Thromb Haemost. 2017. PMID: 27786337 No abstract available.
Similar articles
-
The risk of venous thromboembolism in patients with hepatitis C. A systematic review and meta-analysis.Thromb Haemost. 2016 Oct 28;116(5):958-966. doi: 10.1160/TH16-03-0185. Epub 2016 Jul 14. Thromb Haemost. 2016. PMID: 27411407
-
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.J Thromb Haemost. 2016 May;14(5):964-72. doi: 10.1111/jth.13279. Epub 2016 Mar 15. J Thromb Haemost. 2016. PMID: 26845754
-
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3. Cochrane Database Syst Rev. 2018. PMID: 29687454 Free PMC article.
-
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Nov 08;11:CD010837. doi: 10.1002/14651858.CD010837.pub4. PMID: 28832905 Free PMC article. Updated.
-
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2. Cochrane Database Syst Rev. 2022. PMID: 36413425 Free PMC article.
Cited by
-
Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management.Cureus. 2022 Apr 3;14(4):e23785. doi: 10.7759/cureus.23785. eCollection 2022 Apr. Cureus. 2022. PMID: 35518552 Free PMC article. Review.
-
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases.Res Pract Thromb Haemost. 2017 Aug 5;1(2):150-161. doi: 10.1002/rth2.12028. eCollection 2017 Oct. Res Pract Thromb Haemost. 2017. PMID: 30046685 Free PMC article. Review.
-
Safety of direct oral anticoagulants in patients with advanced liver disease.Liver Int. 2021 Sep;41(9):2159-2170. doi: 10.1111/liv.14992. Epub 2021 Jul 10. Liver Int. 2021. PMID: 34152697 Free PMC article.
-
Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review.Res Pract Thromb Haemost. 2022 May 22;6(4):e12724. doi: 10.1002/rth2.12724. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 36204546 Free PMC article.
-
Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.Res Pract Thromb Haemost. 2023 Jan 14;7(1):100052. doi: 10.1016/j.rpth.2023.100052. eCollection 2023 Jan. Res Pract Thromb Haemost. 2023. PMID: 36846648 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical